{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:37:46Z","timestamp":1791398266896,"version":"4.3.3"},"reference-count":146,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sleep Medicine Reviews"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.smrv.2005.01.005","type":"journal-article","created":{"date-parts":[[2005,6,25]],"date-time":"2005-06-25T07:39:04Z","timestamp":1119685144000},"page":"253-268","source":"Crossref","is-referenced-by-count":46,"title":["Hypocretins (orexins): clinical impact of the discovery of a neurotransmitter"],"prefix":"10.1016","volume":"9","author":[{"given":"Christian R.","family":"Baumann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio L.","family":"Bassetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.smrv.2005.01.005_bib1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/00005053-193003000-00001","article-title":"Sleep as a problem of localization","volume":"71","author":"von Economo","year":"1930","journal-title":"J Nervous Mental Disord"},{"key":"10.1016\/j.smrv.2005.01.005_bib2","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1073\/pnas.95.1.322","article-title":"The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity","volume":"95","author":"De Lecea","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.smrv.2005.01.005_bib3","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behaviour","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.smrv.2005.01.005_bib4","doi-asserted-by":"crossref","first-page":"17771","DOI":"10.1074\/jbc.274.25.17771","article-title":"Structure and function of human prepro-orexin gene","volume":"274","author":"Sakurai","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.smrv.2005.01.005_bib5","doi-asserted-by":"crossref","first-page":"8733","DOI":"10.1073\/pnas.93.16.8733","article-title":"Overview of the most prevalent hypothalamus-specific mRNAs, as identified by directional tag PCR subtraction","volume":"93","author":"Gautvik","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.smrv.2005.01.005_bib6","doi-asserted-by":"crossref","first-page":"7962","DOI":"10.1523\/JNEUROSCI.18-19-07962.1998","article-title":"Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin\/orexin","volume":"18","author":"van den Pol","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.smrv.2005.01.005_bib7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0006-8993(02)04233-6","article-title":"Identification of neurons containing orexin-B (hypocretin-2) immunoreactivity in limbic structures","volume":"967","author":"Ciriello","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.smrv.2005.01.005_bib8","doi-asserted-by":"crossref","first-page":"9996","DOI":"10.1523\/JNEUROSCI.18-23-09996.1998","article-title":"Neurons containing hypocretin (orexin) project to multiple neuronal systems","volume":"18","author":"Peyron","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.smrv.2005.01.005_bib9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0014-5793(99)01030-3","article-title":"Distribution and quantification of immunoreactive orexin A in rat tissues","volume":"457","author":"Taheri","year":"1999","journal-title":"FEBS Lett"},{"key":"10.1016\/j.smrv.2005.01.005_bib10","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1111\/j.1460-9568.2004.03243.x","article-title":"Orexin (hypocretin)\/dynorphin neurons control GABAergic inputs to tuberomamillary neurons","volume":"19","author":"Eriksson","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.smrv.2005.01.005_bib11","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/nn944","article-title":"Sleeping with the hypothalamus: emerging therapeutic targets for sleep disorders","volume":"5","author":"Mignot","year":"2002","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.smrv.2005.01.005_bib12","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1523\/JNEUROSCI.19-08-03171.1999","article-title":"Hypothalamic hypocretin (orexin): robust innervation of the spinal cord","volume":"19","author":"van den Pol","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.smrv.2005.01.005_bib13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0028-3908(00)00178-7","article-title":"Orexin-A excites serotoninergic neurons in the dorsal raphe nucleus of the rat","volume":"40","author":"Brown","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.smrv.2005.01.005_bib14","doi-asserted-by":"crossref","first-page":"9273","DOI":"10.1523\/JNEUROSCI.21-23-09273.2001","article-title":"Orexin\/hypocretin excites the histaminergic neurons of the tuberomamillary nucleus","volume":"21","author":"Eriksson","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.smrv.2005.01.005_bib15","doi-asserted-by":"crossref","first-page":"10911","DOI":"10.1073\/pnas.96.19.10911","article-title":"Orexin A activates locus coeruleus cell firing and increases arousal in the rat","volume":"96","author":"Hagan","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.smrv.2005.01.005_bib16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0014-5793(98)01266-6","article-title":"Distribution of orexin receptors mRNA in the rat brain","volume":"438","author":"Trivedi","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1016\/j.smrv.2005.01.005_bib17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/cne.1190","article-title":"Differential expression of orexin receptors 1 and 2 in the rat brain","volume":"435","author":"Marcus","year":"2001","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.smrv.2005.01.005_bib18","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0304-3940(03)00571-8","article-title":"Differential kinetics of hypocretins in the cerebrospinal fluid after intracerebroventricular administration in rats","volume":"346","author":"Yoshida","year":"2003","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.smrv.2005.01.005_bib19","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1152\/jn.00001.2003","article-title":"Effects of orexin (hypocretin) on GIRK channels","volume":"90","author":"Hoang","year":"2003","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.smrv.2005.01.005_bib20","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0896-6273(02)01132-7","article-title":"Hypocretin\/Orexin excites hypocretin neurons via a local glutamate neuron-A potential mechanism for orchestrating the hypothalamic arousal system","volume":"36","author":"Li","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.smrv.2005.01.005_bib21","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1523\/JNEUROSCI.23-05-01557.2003","article-title":"The wake-promoting hypocretin-orexin neurons are in an intrinsic state of membrane depolarization","volume":"23","author":"Eggermann","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.smrv.2005.01.005_bib22","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1523\/JNEUROSCI.21-05-01656.2001","article-title":"Fos expression in orexin neurons varies with behavioral state","volume":"21","author":"Estabrooke","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.smrv.2005.01.005_bib23","doi-asserted-by":"crossref","first-page":"7835","DOI":"10.1523\/JNEUROSCI.22-18-07835.2002","article-title":"Selective action of orexin (hypocretin) on nonspecific thalamocortical projection neurons","volume":"22","author":"Bayer","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.smrv.2005.01.005_bib24","first-page":"9273","article-title":"Decreased brain histamine content in hypocretin\/orexin receptor-2 mutated narcoleptic dogs","volume":"21","author":"Nishino","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.smrv.2005.01.005_bib25","doi-asserted-by":"crossref","first-page":"9965","DOI":"10.1073\/pnas.181330998","article-title":"Arousal effect of orexin A depends on activation of the histaminergic system","volume":"98","author":"Huang","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.smrv.2005.01.005_bib26","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0166-2236(00)02002-6","article-title":"The sleep switch: hypothalamic control of sleep and wakefulness","volume":"24","author":"Saper","year":"2001","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.smrv.2005.01.005_bib27","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/bies.1058","article-title":"Hypocretin\/orexin, sleep and narcolepsy","volume":"12","author":"Hungs","year":"2001","journal-title":"Bioessays"},{"key":"10.1016\/j.smrv.2005.01.005_bib28","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0166-2236(00)01594-0","article-title":"The hypocretin\/orexin ligand-receptor system: implications for sleep and sleep disorders","volume":"35","author":"Kilduff","year":"2000","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.smrv.2005.01.005_bib29","first-page":"25","article-title":"Hypothalamic neurons that contain hypocretin (orexin) express c-fos during active wakefulness and carbachol-induced active sleep","volume":"4","author":"Torterolo","year":"2001","journal-title":"Sleep Res"},{"key":"10.1016\/j.smrv.2005.01.005_bib30","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1113\/jphysiol.2001.012888","article-title":"Sleep-waking discharge patterns of neurons recorded in the rat perifornical lateral hypothalamic area","volume":"538","author":"Alam","year":"2002","journal-title":"J Physiol"},{"key":"10.1016\/j.smrv.2005.01.005_bib31","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1113\/jphysiol.2002.038729","article-title":"Intravenously administered hypocretin-1 alters brain amino acid release: an in vivo microdialysis study in rats","volume":"548","author":"John","year":"2003","journal-title":"J Physiol"},{"key":"10.1016\/j.smrv.2005.01.005_bib32","doi-asserted-by":"crossref","first-page":"5282","DOI":"10.1523\/JNEUROSCI.22-13-05282.2002","article-title":"Release of hypocretin (orexin) during waking and sleep states","volume":"22","author":"Kiyashchenko","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.smrv.2005.01.005_bib33","first-page":"435","article-title":"The suprachiasmatic nucleus projects to posterior hypothalamic arousal systems","volume":"12","author":"Abrahamson","year":"2001","journal-title":"Neuro Rep"},{"key":"10.1016\/j.smrv.2005.01.005_bib34","doi-asserted-by":"crossref","first-page":"10691","DOI":"10.1523\/JNEUROSCI.23-33-10691.2003","article-title":"Critical role of dorsomedial hypothalamic nucleus in a wide range of behavioral circadian rhythms","volume":"23","author":"Chou","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.smrv.2005.01.005_bib35","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1046\/j.0953-816x.2001.01725.x","article-title":"Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to the light-dark cycle and sleep-wake activities","volume":"14","author":"Yoshida","year":"2001","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.smrv.2005.01.005_bib36","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0304-3940(94)90841-9","article-title":"Paradoxical timing of the circadian rhythm of sleep propensity serves to consolidate sleep and wakefulness in humans","volume":"166","author":"Dijk","year":"1994","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.smrv.2005.01.005_bib37","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/89522","article-title":"A neural circuit for circadian regulation of arousal","volume":"4","author":"Aston-Jones","year":"2001","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.smrv.2005.01.005_bib38","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0306-4522(03)00334-8","article-title":"Fos immunoreactivity in hypocretin-synthesizing and hypocretin-1 receptor-expressing neurons: effects of diurnal and nocturnal spontaneous waking, stress and hypocretin-1 administration","volume":"121","author":"Espana","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.smrv.2005.01.005_bib39","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/sleep\/27.4.619","article-title":"Lesions of the suprachiasmatic nucleus eliminate the daily rhythm of hypocretin-1 release","volume":"27","author":"Zhang","year":"2004","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2005.01.005_bib40","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.1523\/JNEUROSCI.0586-04.2004","article-title":"Behavioral state instability in orexin knock-out mice","volume":"24","author":"Mochizuki","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.smrv.2005.01.005_bib41","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1523\/JNEUROSCI.23-08-03555.2003","article-title":"Circadian and homeostatic regulation of hypocretin in a primate model: implications for the consolidation of wakefulness","volume":"23","author":"Zeitzer","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.smrv.2005.01.005_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2003.09.032","article-title":"Increased hypocretin-1 levels in cerebrospinal fluid after REM sleep deprivation","volume":"995","author":"Pedrazzoli","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.smrv.2005.01.005_bib43","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0006-8993(99)01131-2","article-title":"Effect of lateral cerebroventricular injection of the appetite-stimulating neuropeptide, orexin and neuropeptide Y, on the various behavioral activities of rats","volume":"821","author":"Ida","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.smrv.2005.01.005_bib44","first-page":"25","article-title":"Hypocretinergic neurons are primarily involved in activation of the somatomotor system","volume":"26","author":"Torterolo","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2005.01.005_bib45","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.regpep.2003.10.003","article-title":"Increased hypocretin-1 (orexin-a) levels in cerebrospinal fluid of rats after short-term forced activity","volume":"117","author":"Martins","year":"2004","journal-title":"Regul Pept"},{"key":"10.1016\/j.smrv.2005.01.005_bib46","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1113\/jphysiol.2004.061606","article-title":"Locomotor-dependent and -independent components to hypocretin-1 (orexin A) regulation in a sleep\/wake consolidating monkey","volume":"557","author":"Zeitzer","year":"2004","journal-title":"J Physiol"},{"key":"10.1016\/j.smrv.2005.01.005_bib47","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1152\/jn.2001.85.5.2008","article-title":"Increased and decreased muscle tone with orexin (hypocretin) microinjections in the locus coeruleus and pontine inhibitory area","volume":"85","author":"Kiyashchenko","year":"2001","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.smrv.2005.01.005_bib48","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/s1389-9457(02)00191-0","article-title":"The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A)","volume":"4","author":"Bassetti","year":"2003","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2005.01.005_bib49","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(04)15951-5","article-title":"A monozygotic twin pair concordant for narcolepsy-cataplexy without any detectable abnormality in the hypocretin (orexin) pathway","volume":"363","author":"Khatami","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.smrv.2005.01.005_bib50","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/archneur.59.10.1553","article-title":"The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias","volume":"59","author":"Mignot","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.smrv.2005.01.005_bib51","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1136\/jnnp.74.12.1667","article-title":"CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome and other hypersomnia and neurological conditions","volume":"74","author":"Dauvilliers","year":"2003","journal-title":"J Neurol Neurochir Psychiatry"},{"key":"10.1016\/j.smrv.2005.01.005_bib52","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/sleep\/25.7.733","article-title":"Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: relationship to cataplexy and HLA DQB1*0602 status","volume":"25","author":"Krahn","year":"2002","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2005.01.005_bib53","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1365-2869.2002.00284.x","article-title":"CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia","volume":"11","author":"Kanbayashi","year":"2002","journal-title":"J Sleep Res"},{"key":"10.1016\/j.smrv.2005.01.005_bib54","first-page":"1199","article-title":"Orexins (hypocretins): their role in appetite and arousal","volume":"3","author":"Preti","year":"2002","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.smrv.2005.01.005_bib55","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0092-8674(00)81973-X","article-title":"Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation","volume":"98","author":"Chemelli","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.smrv.2005.01.005_bib56","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0896-6273(01)00293-8","article-title":"Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia and obesity","volume":"30","author":"Hara","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.smrv.2005.01.005_bib57","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s004060170057","article-title":"Increased prevalence of obesity in narcoleptic patients and relatives","volume":"251","author":"Dahmen","year":"2001","journal-title":"Euro Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.smrv.2005.01.005_bib58","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/oby.2003.156","article-title":"Hypocretin deficiency in narcoleptic humans is associated with abdominal obesity","volume":"11","author":"Kok","year":"2003","journal-title":"Obes Res"},{"key":"10.1016\/j.smrv.2005.01.005_bib59","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0013-4694(88)90145-9","article-title":"Ambulatory 24h sleep-wake monitoring in narcolepsy-cataplexy compared to matched controls","volume":"70","author":"Broughton","year":"1988","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1016\/j.smrv.2005.01.005_bib60","first-page":"159","article-title":"Impaired circadian waking arousal in narcolepsy-cataplexy","volume":"1","author":"Broughton","year":"1998","journal-title":"Sleep Res Online"},{"key":"10.1016\/j.smrv.2005.01.005_bib61","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/(SICI)1096-9861(19981228)402:4<460::AID-CNE3>3.0.CO;2-S","article-title":"Hypocretin\/orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: relationship to the neuropeptide Y and agouti gene-related protein systems","volume":"402","author":"Broberger","year":"1998","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.smrv.2005.01.005_bib62","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nn1226","article-title":"Orexin-sensitive NPY\/AgRP pacemaker neurons in the hypothalamic arcuate nucleus","volume":"7","author":"van den Top","year":"2004","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.smrv.2005.01.005_bib63","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1523\/JNEUROSCI.19-03-01072.1999","article-title":"Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: a novel circuit implicated in metabolic and endocrine regulations","volume":"19","author":"Horvath","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.smrv.2005.01.005_bib64","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0006-8993(02)02941-4","article-title":"Interactions of neuropeptide Y, hypocretin-I (orexin A) and melanin-concentrating hormone on feeding in rats","volume":"944","author":"Sahu","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.smrv.2005.01.005_bib65","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0959-4388(02)00331-8","article-title":"Sleep, feeding and neuropeptides: roles of orexins and orexin receptors","volume":"12","author":"Mieda","year":"2002","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.smrv.2005.01.005_bib66","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0896-6273(03)00331-3","article-title":"Hypothalamix orexin neurons regulate arousal according to energy balance in mice","volume":"38","author":"Yamanaka","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.smrv.2005.01.005_bib67","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s002130000551","article-title":"Effects of centrally administered orexin-B and orexin-A: a role for orexin-1 receptors in orexin-B-induced hyperactivity","volume":"153","author":"Jones","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.smrv.2005.01.005_bib68","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0306-4522(02)00877-1","article-title":"Orexin A (hypocretin-1) application at the medial preoptic area potentiates male sexual behavior in rats","volume":"116","author":"Gulia","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.smrv.2005.01.005_bib69","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1210\/jc.87.2.805","article-title":"Reduction of plasma leptin levels and loss of its circadian rhythmicity in hypocretin (orexin)-deficient narcoleptic humans","volume":"87","author":"Kok","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.smrv.2005.01.005_bib70","doi-asserted-by":"crossref","first-page":"E630","DOI":"10.1152\/ajpendo.00060.2004","article-title":"Pulsatile LH release is diminished, while FSH secretion is normal in hypocretin deficient narcoleptic men","volume":"287","author":"Kok","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.smrv.2005.01.005_bib71","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0006-8993(99)01457-2","article-title":"Cardiovascular regulatory actions of the hypocretins in brain","volume":"831","author":"Samson","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.smrv.2005.01.005_bib72","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.neuroscience.2003.07.008","article-title":"Orexin neurons project to diverse sympathetic outflow systems","volume":"122","author":"Geerling","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.smrv.2005.01.005_bib73","doi-asserted-by":"crossref","first-page":"R1611","DOI":"10.1152\/ajpregu.00719.2002","article-title":"Cardiac effects of hypocretin-1 in nucleus ambiguus","volume":"284","author":"Ciriello","year":"2003","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.smrv.2005.01.005_bib74","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0006-8993(01)02606-3","article-title":"Inhibition of prostaglandin synthesis reduces hyperthermic reactions induced by hypocretin-1\/orexin A","volume":"909","author":"Monda","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.smrv.2005.01.005_bib75","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1523\/JNEUROSCI.5560-03.2004","article-title":"Expression of a poly-glutamine-ataxin-3 transgene in orexin neurons induces narcolepsy-cataplexy in the rat","volume":"24","author":"Beuckmann","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.smrv.2005.01.005_bib76","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0896-6273(03)00330-1","article-title":"Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of non-REM and REM sleep regulatory processes","volume":"38","author":"Willie","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.smrv.2005.01.005_bib77","doi-asserted-by":"crossref","first-page":"7273","DOI":"10.1523\/JNEUROSCI.21-18-07273.2001","article-title":"Hypocretin-2-saporin lesions of the lateral hypothalamus produce narcoleptic-like sleep behavior in the rat","volume":"21","author":"Gerashchenko","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.smrv.2005.01.005_bib78","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0306-4522(02)00575-4","article-title":"Effects of lateral hypothalamic lesion with the neurotoxin hypocretin-2-saporin on sleep in Long-Evans rats","volume":"116","author":"Gerashchenko","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.smrv.2005.01.005_bib79","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0092-8674(00)81965-0","article-title":"The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene","volume":"98","author":"Lin","year":"1999","journal-title":"Cell"},{"issue":"Suppl. 23","key":"10.1016\/j.smrv.2005.01.005_bib80","first-page":"A91","article-title":"Preservation of hypocretin neurons in genetically narcoleptic dogs","volume":"23","author":"Thannikal","year":"2000","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2005.01.005_bib81","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1006\/nbdi.2001.0389","article-title":"Hypocretin levels in sporadic and familial canine narcolepsy","volume":"8","author":"Ripley","year":"2001","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.smrv.2005.01.005_bib82","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/79690","article-title":"A mutation in early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains","volume":"6","author":"Peyron","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.smrv.2005.01.005_bib83","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1750-3639.2003.tb00033.x","article-title":"Pattern of hypocretin (orexin) soma and axon loss, and gliosis, in human narcolepsy","volume":"13","author":"Thannickal","year":"2003","journal-title":"Brain Pathol"},{"key":"10.1016\/j.smrv.2005.01.005_bib84","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/nm1102-1186","article-title":"Hypothalamic gray matter changes in narcoleptic patients","volume":"8","author":"Draganski","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.smrv.2005.01.005_bib85","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1212\/WNL.58.12.1852","article-title":"Reduced cortical gray matter in narcolepsy: preliminary findings with voxel-based morphometry","volume":"58","author":"Kaufmann","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2005.01.005_bib86","first-page":"44","article-title":"Voxel-based morphometry in hypocretin-deficient narcolepsy","volume":"26","author":"Overeem","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2005.01.005_bib87","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/sleep\/20.8.630","article-title":"MRI findings in narcolepsy","volume":"20","author":"Bassetti","year":"1997","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2005.01.005_bib88","first-page":"620","article-title":"Value of the multiple sleep latency test (MSLT) for the diagnosis of narcolepsy","volume":"20","author":"Aldrich","year":"1997","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2005.01.005_bib89","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1212\/WNL.43.1_Part_1.55","article-title":"The positive diagnosis of narcolepsy and narcolepsy's borderland","volume":"43","author":"Moscovitch","year":"1993","journal-title":"Neurology"},{"issue":"Suppl. 1","key":"10.1016\/j.smrv.2005.01.005_bib90","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1212\/WNL.50.2_Suppl_1.S16","article-title":"Genetic and familial aspects of narcolepsy","volume":"50","author":"Mignot","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2005.01.005_bib91","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/sleep\/25.1.27","article-title":"Clinical aspects of narcolepsy-cataplexy across ethnic groups","volume":"25","author":"Okun","year":"2002","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2005.01.005_bib92","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(99)05582-8","article-title":"Hypocretin (orexin) deficiency in human narcolepsy","volume":"355","author":"Nishino","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.smrv.2005.01.005_bib93","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1093\/brain\/120.8.1423","article-title":"Idiopathic hypersomnia. A series of 42 patients","volume":"120","author":"Bassetti","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.smrv.2005.01.005_bib94","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1212\/WNL.57.12.2253","article-title":"CSF hypocretin\/orexin levels in narcolepsy and other neurologic conditions","volume":"58","author":"Ripley","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2005.01.005_bib95","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000079749","article-title":"Normal CSF hypocretin-1 (orexin A) levels in dementia with Lewy bodies associated with excessive daytime sleepiness","volume":"52","author":"Baumann","year":"2004","journal-title":"Eur Neurol"},{"key":"10.1016\/j.smrv.2005.01.005_bib96","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0006-3223(02)01740-7","article-title":"Diurnal variation of cerebrospinal fluid hypocretin-1 (Orexin-A) levels in control and depressed subjects","volume":"54","author":"Salomon","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.smrv.2005.01.005_bib97","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/jnnp.74.1.127","article-title":"Hypocretin (orexin) deficiency in narcolepsy and primary hypersomnia","volume":"74","author":"Ebrahim","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.smrv.2005.01.005_bib98","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0304-3940(01)02476-4","article-title":"Plasma orexin-A is lower in patients with narcolepsy","volume":"318","author":"Higuchi","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.smrv.2005.01.005_bib99","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1212\/WNL.56.12.1749","article-title":"Normal plasma levels of orexin A (hypocretin-1) in narcoleptic patients","volume":"56","author":"Dalal","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2005.01.005_bib100","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1389-9457(02)00078-3","article-title":"Article reviewed: plasma orexin A is lower in patients with narcolepsy","volume":"3","author":"Nishino","year":"2002","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2005.01.005_bib101","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S0014-4886(03)00388-1","article-title":"Relationship between CSF hypocretin levels and hypocretin neuronal loss","volume":"184","author":"Gerashchenko","year":"2003","journal-title":"Exp Neurol"},{"key":"10.1016\/j.smrv.2005.01.005_bib102","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/ana.20208","article-title":"A narcolepsy susceptibility locus maps to a 5Mb region of chromosome 21q","volume":"56","author":"Dauvilliers","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.smrv.2005.01.005_bib103","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/sleep\/26.5.555","article-title":"Decreased cerebrospinal fluid hypocretin-1 levels near the onset of narcolepsy in 2 prepubertal children","volume":"26","author":"Kubota","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2005.01.005_bib104","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ana.1130","article-title":"Low cerebrospinal fluid hypocretin (orexin) and altered energy homeostasis in human narcolepsy","volume":"50","author":"Nishino","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.smrv.2005.01.005_bib105","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/ana.10164","article-title":"Low cerebrospinal fluid hypocretin (orexin) and altered energy homeostasis in human narcolepsy","volume":"51","author":"Schuld","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.smrv.2005.01.005_bib106","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1212\/WNL.57.10.1896","article-title":"Polymorphisms in hypocretin\/orexin pathway genes and narcolepsy","volume":"57","author":"Olafsdottir","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2005.01.005_bib107","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1212\/WNL.57.10.1893","article-title":"Polymorphisms in the vicinity of the hypocretin\/orexin are not associated with human narcolepsy","volume":"57","author":"Hungs","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2005.01.005_bib108","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1212\/WNL.56.1.115","article-title":"A prepro-orexin gene polymorphism is associated with narcolepsy","volume":"56","author":"Gencik","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2005.01.005_bib109","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00041444-200403000-00008","article-title":"A rare form of narcolepsy (HLA-DR2-) shows possible association with (functionally relevant) alpha-interferon gene polymorphisms","volume":"14","author":"Wieczorek","year":"2004","journal-title":"Psychiatr Genet"},{"key":"10.1016\/j.smrv.2005.01.005_bib110","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1600-0404.1990.tb00978.x","article-title":"CSF immune variables in patients with narcolepsy","volume":"81","author":"Fredrikson","year":"1990","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.smrv.2005.01.005_bib111","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1212\/01.WNL.0000101718.92619.67","article-title":"Hypocretin-1 CSF levels in anti-Ma2 associated encephalitis","volume":"62","author":"Overeem","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2005.01.005_bib112","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0304-3940(03)00085-5","article-title":"Screening for anti-ganglioside antibodies in hypocretin-deficient human narcolepsy","volume":"341","author":"Overeem","year":"2003","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.smrv.2005.01.005_bib113","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/sleep\/25.7.719","article-title":"Search for neuron-specific and nonneuron-specific antibodies in narcoleptic patients with and without HLA DQB1*0602","volume":"25","author":"Black","year":"2002","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2005.01.005_bib114","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2869.2003.00380.x","article-title":"Clinical efficacy of high-dose intravenous immunoglobulins near the onset of narcolepsy in a 10-year-old boy","volume":"12","author":"Lecendreux","year":"2003","journal-title":"J Sleep Res"},{"key":"10.1016\/j.smrv.2005.01.005_bib115","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/sleep\/26.7.809","article-title":"Report of a case of immunosuppression with prednisone in an 8-year-old boy with an acute onset of hypocretin-deficiency narcolepsy","volume":"26","author":"Hecht","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2005.01.005_bib116","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1073\/pnas.0400590101","article-title":"Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice","volume":"101","author":"Mieda","year":"2004","journal-title":"PNAS"},{"key":"10.1016\/j.smrv.2005.01.005_bib117","first-page":"219","article-title":"Orexin A but not orexin B rapidly enters brain from blood by simple diffusion","volume":"289","author":"Kastin","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.smrv.2005.01.005_bib118","first-page":"23","article-title":"Systemic administration of hypocretin-1 reduces cataplexy and normalizes sleep and waking durations in narcoleptic dogs","volume":"3","author":"John","year":"2000","journal-title":"Sleep Res Online"},{"key":"10.1016\/j.smrv.2005.01.005_bib119","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/sleep\/26.8.953","article-title":"Effects of IV and ICV hypocretin-1 (orexin A) in hypocretin receptor-2 gene mutated narcoleptic dogs and IV hypocretin-1 replacement therapy in a hypocretin-ligand-deficient narcoleptic dog","volume":"26","author":"Fujiki","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2005.01.005_bib120","doi-asserted-by":"crossref","first-page":"8620","DOI":"10.1523\/JNEUROSCI.20-22-08620.2000","article-title":"Hypothalamic arousal regions are activated during modafinil-induced wakefulness","volume":"20","author":"Scammell","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.smrv.2005.01.005_bib121","first-page":"19","article-title":"Effect of the wake-promoting agent modafinil on sleep-promoting neurons from the ventrolateral preoptic nucleus: an in vitro pharmacologic study","volume":"27","author":"Gallopin","year":"2004","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2005.01.005_bib122","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1358\/dnp.2003.16.10.829298","article-title":"Drugs to interfere with orexins (hypocretins)","volume":"16","author":"Selbach","year":"2003","journal-title":"Drug News Perspect"},{"key":"10.1016\/j.smrv.2005.01.005_bib123","first-page":"205","article-title":"Cerebrospinal fluid levels of hypocretin (orexin) in hypersomnolent patients without cataplexy","volume":"7","author":"Bassetti","year":"2001","journal-title":"Actas Fisiolog"},{"key":"10.1016\/j.smrv.2005.01.005_bib124","first-page":"1068","article-title":"Normal hypocretin-1 levels in the cerebrospinal fluid of patients with fatal familial insomnia","volume":"26","author":"Martinez-Rodriguez","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2005.01.005_bib125","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1212\/WNL.56.12.1751","article-title":"Narcolepsy and low CSF orexin (hypocretin) concentration after a diencephalic stroke","volume":"56","author":"Scammell","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2005.01.005_bib126","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1212\/WNL.56.12.1775","article-title":"A hypersomnolent girl with decreased CSF hypocretin level after removal of a hypothalamic tumor","volume":"56","author":"Arii","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2005.01.005_bib127","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1177\/088307380201700713","article-title":"A case of acute disseminated encephalomyelitis presenting hypersomnia with decreased hypocretin level in cerebrospinal fluid","volume":"17","author":"Kubota","year":"2002","journal-title":"J Child Neurol"},{"key":"10.1016\/j.smrv.2005.01.005_bib128","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2169\/internalmedicine.42.743","article-title":"Hypersomnia and low CSF hypocretin-1 (orexin-A) concentration in a patient with multiple sclerosis showing bilateral hypothalamic lesions","volume":"42","author":"Kato","year":"2003","journal-title":"Int Med"},{"key":"10.1016\/j.smrv.2005.01.005_bib129","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/archneur.61.5.758","article-title":"Narcolepsy caused by acute disseminated encephalomyelitis","volume":"61","author":"Gledhill","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.smrv.2005.01.005_bib130","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1212\/01.WNL.0000078191.19709.C0","article-title":"Acquired narcolepsy in an acromegalic patient who underwent pituitary irradiation","volume":"61","author":"Dempsey","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2005.01.005_bib131","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1212\/WNL.59.4.639","article-title":"Increased CSF hypocretin-1 (orexin-A) in restless legs syndrome","volume":"59","author":"Allen","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2005.01.005_bib132","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1212\/01.WNL.0000094196.50155.38","article-title":"CSF hypocretin-1 levels in restless legs syndrome","volume":"61","author":"Stiasny-Kolster","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2005.01.005_bib133","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/sleep\/26.3.287","article-title":"Decreased hypocretin-1 (orexin A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepiness","volume":"26","author":"Martinez-Rodriguez","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2005.01.005_bib134","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/sleep\/26.4.427","article-title":"Sleep disturbances and hypocretin deficiency in Niemann-Pick disease type C","volume":"26","author":"Vankova","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2005.01.005_bib135","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1365-2869.2002.00311.x","article-title":"Transient total sleep loss in cerebral Whipple's disease: a longitudinal study","volume":"11","author":"Voderholzer","year":"2002","journal-title":"J Sleep Res"},{"key":"10.1016\/j.smrv.2005.01.005_bib136","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1212\/01.WNL.0000078194.53210.48","article-title":"Low levels of ventricular CSF orexin\/hypocretin in advanced PD","volume":"61","author":"Drouot","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2005.01.005_bib137","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1212\/01.WNL.0000081049.14098.50","article-title":"CSF hypocretin levels in Guillain\u2013Barre syndrome and other inflammatory neuropathies","volume":"61","author":"Nishino","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2005.01.005_bib138","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1212\/WNL.62.12.2337","article-title":"Normal CSF hypocretin-1 levels in Guillain\u2013Barr\u00e9 syndrome","volume":"62","author":"Baumann","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2005.01.005_bib139","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1212\/WNL.58.3.498","article-title":"Normal hypocretin-1 levels in Parkinson's disease patients with excessive daytime sleepiness","volume":"58","author":"Overeem","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2005.01.005_bib140","doi-asserted-by":"crossref","unstructured":"Baumann CR, Ferini-Strambi L, Waldvogel D, Werth E, Bassetti CL. Parkinsonism with excessive daytime sleepiness: A narcolepsy-like disorder? J Neurol 2005:252:139--45.","DOI":"10.1007\/s00415-005-0614-5"},{"key":"10.1016\/j.smrv.2005.01.005_bib141","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0006-3223(02)01740-7","article-title":"Diurnal variation of cerebrospinal fluid hypocretin-1 (Orexin-A) levels in control and depressed subjects","volume":"54","author":"Salomon","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.smrv.2005.01.005_bib142","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/sj.mp.4001363","article-title":"Lower CSF orexin A (hypocretin-1) levels in patients with schizophrenia treated with haloperidol compared to unmedicated subjects","volume":"8","author":"Dalal","year":"2003","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.smrv.2005.01.005_bib143","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.0962-1105.2003.00373.x","article-title":"CSF hypocretin measures in patients with obstructive sleep apnea","volume":"12","author":"Kanbayashi","year":"2003","journal-title":"J Sleep Res"},{"issue":"Suppl","key":"10.1016\/j.smrv.2005.01.005_bib144","first-page":"A496","article-title":"CSF hypocretin concentration in various neurologic disorders and sleep apnea syndrome","volume":"25","author":"Kanbayashi","year":"2002","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2005.01.005_bib145","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1212\/01.WNL.0000125284.19326.80","article-title":"Undetectable CSF hypocretin-1 in Hashimoto's encephalopathy associated with coma","volume":"62","author":"Castillo","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2005.01.005_bib146","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00415-004-0442-z","article-title":"Low CSF hypocretin-1\/orexin-A associated with hypersomnia secondary to hypothalamic lesion in a case of multiple sclerosis","volume":"251","author":"Oka","year":"2004","journal-title":"J Neurol"}],"container-title":["Sleep Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1087079205000079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1087079205000079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T22:47:43Z","timestamp":1551307663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1087079205000079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":146,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S1087079205000079"],"URL":"https:\/\/doi.org\/10.1016\/j.smrv.2005.01.005","relation":{},"ISSN":["1087-0792"],"issn-type":[{"value":"1087-0792","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}